相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States
Donghee Kim et al.
HEPATOLOGY (2019)
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal et al.
HEPATOLOGY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Collectin-11 Promotes the Development of Renal Tubulointerstitial Fibrosis
Weiju Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease
Isabelle D. Munsterman et al.
HISTOPATHOLOGY (2018)
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar-Gomez et al.
JOURNAL OF HEPATOLOGY (2018)
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
Anna Lidofsky et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
Cheng-Jie Lin et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease
S. Lefere et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling
Jiaying Lu et al.
LABORATORY INVESTIGATION (2017)
IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study
Hannes Hagstrom et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
G. Craig Wood et al.
SCIENTIFIC REPORTS (2017)
Assessment of Variability in the SOMAscan Assay
Julian Candia et al.
SCIENTIFIC REPORTS (2017)
Use of Mac-2 Binding Protein as a Biomarker for Nonalcoholic Fatty Liver Disease Diagnosis
Yoshihiro Kamada et al.
HEPATOLOGY COMMUNICATIONS (2017)
Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses
Hae-Ki Min et al.
FASEB JOURNAL (2016)
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
Peter Ganz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling
Barbara Bottazzi et al.
JOURNAL OF HEPATOLOGY (2016)
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
Parambir S. Dulai et al.
JOURNAL OF HEPATOLOGY (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Testosterone in men with advanced liver disease: Abnormalities and implications
Marie Sinclair et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers
Xiyong Liu et al.
CARCINOGENESIS (2015)
Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure
Min Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Non-alcoholic fatty liver disease in common endocrine disorders
Jonathan M. Hazlehurst et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology
Yasar Colak et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis
Anuradha Krishnan et al.
LABORATORY INVESTIGATION (2012)
Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line
XM Wang et al.
HEPATOLOGY (2005)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury
S Sanz et al.
GUT (2005)
Circulating concentrations of interleukin-18, interleukin-18 binding protein, and γ interferon in patients with alcoholic hepatitis
L Spahr et al.
LIVER INTERNATIONAL (2004)
Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls
R Kaaks et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2003)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury
EC Hsiao et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
